WCG acquisition expands company's investigator/site database

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/cybrain)
(Image: iStock/cybrain)

Related tags Clinical trial

The exclusive license agreement expands WCG’s clinical trial activation solution, which seeks to accelerate study start-up for sponsors and CROs.

WIRB-Copernicus Group (WCG) announced the agreement with karmadata, a clinical trial database and decision support application company, today.

karmadata​ uses big data and cloud technologies to standardize and link healthcare data from various open data sources, such as WHO, NIH, and the CDC, in addition to private sources, like private pharmacy and medical claims, among others.

As part of the agreement, WCG will acquire a suite of proprietary applications from karmadata which, according to the company, are designed to facilitate the management of clinical trial data​.

Additionally, WCG will receive an exclusive license to use karmadata’s global library of clinical trial investigator and site data.

Our clients continue to look for ways to accelerate patient access to innovative medicines by increasing the productivity of the drug development process​,” said Donald A. Deieso, PhD, chairman and CEO of WCG.

Through the acquisition of karmadata’s proprietary clinical trials database and big data technologies, we will be able to help them drive an even greater return on investment in the conduct of clinical trials​.”

According to WCG, the addition of karmadata’s global investigator data to the company’s existing investigator/site database will help its clients better plan and conduct site feasibility activities.

At karmadata, it is our mission to use data and technology to transform the healthcare industry​,” said Sean Power, founder and CEO of karmadata.

We are at a tipping point, and WCG is in a unique position to fundamentally change how sponsors, physicians, and patients experience a clinical trial​.”

Related news

Related products

show more

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us

Products

View more

Webinars